1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Outset Medical Inc

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.


Why Shares of Outset Medical Are Down Tuesday
Feb 14, 2023 17:10pm

The medical technology company, which makes a portable dialysis machine, delivered its fourth-quarter and full-year report on Monday.

Source:The Motley Fool
Outset Medical''s Return On Capital Employed Insights
Feb 14, 2023 14:47pm

Benzinga Pro data, Outset Medical (NASDAQ: OM ) reported Q4 sales of $32.01 million. Earnings fell to a loss of $41.44 million, resulting in a 1.63% decrease from last quarter. Outset Medical collected $27.76 million in revenue during Q3, but reported earnings showed a $40.78 million loss. What Is ROCE? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and is a … Full story available on

RBC Capital Remains Positive on Outset Medical Inc.
Feb 14, 2023 14:47pm
The GEO, Outset Medical, Cerberus Cyber Sentinel among premarket losers'' pack
Feb 14, 2023 13:26pm

Soligenix SNGX -40% as FDA declines to review photodynamic therapy for cancer.Energy Services of America ESOA -26% on Q1 earnings release.T2 Biosystems TTOO -16% on…

Source:Seeking Alpha
Outset Medical, Inc. (OM) Q4 2022 Earnings Call Transcript
Feb 14, 2023 04:12am

Outset Medical, Inc. (NASDAQ:NASDAQ:OM) Q4 2022 Earnings Conference Call February 13, 2023 5:00 PM ETCompany RepresentativesLeslie Trigg - Chair, Chief Executive OfficerNabeel Ahmed - Chief…

Source:Seeking Alpha
Outset Medical Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 13, 2023 21:05pm

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2022. Recent Highlights Recorded net revenue of $32.0 million in the fourth quarter, a 15.3% increase compared to $27.8 million in the third quarter, and a 14.0% increase compared to $28.2 milli

Source:Business Wire
Earnings Outlook For Outset Medical
Feb 10, 2023 16:01pm

Outset Medical (NASDAQ: OM ) is set to give its latest quarterly earnings report on Monday, 2023-02-13. Here''s what investors need to know before the announcement. Analysts estimate that Outset Medical will report an earnings per share (EPS) of $-0.83. Outset Medical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on

Outset Medical Looks To Grow Revenue But Operating Losses Remain Heavy (NASDAQ:OM)
Jan 25, 2023 18:36pm

Outset looks to improve its revenue growth but operating losses remain very high. Click here to read my analysis of OM stock and why it''s a hold.

Source:Seeking Alpha